SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-13-153125
Filing Date
2013-04-12
Accepted
2013-04-12 16:43:26
Documents
3
Group Members
ORBIMED CAPITAL LLCSAMUEL D. ISALY

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO FORM SCHEDULE 13D d521240dsc13da.htm SC 13D/A 20691
2 EXHIBIT A d521240dex99a.htm EX-99.A 5824
3 EXHIBIT B d521240dex99b.htm EX-99.B 6159
  Complete submission text file 0001193125-13-153125.txt   34297
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13D/A

Mailing Address NO.3 A1, ROAD 10 SHENYANG ECONOMY & TECHNOLOGY DEVELOPMENT ZONE SHENYANG F4 110027
Business Address NO.3 A1, ROAD 10 SHENYANG ECONOMY & TECHNOLOGY DEVELOPMENT ZONE SHENYANG F4 110027 86-24-2581-1820
3SBio Inc. (Subject) CIK: 0001383790 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-82724 | Film No.: 13759100
SIC: 2834 Pharmaceutical Preparations